Kevin M. Egan

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.

NewBiotics, Inc. develops pharmaceutical drugs to treat cancer and infectious disease. It applies its Enzyme Catalyzed Therapeutic Activation technology to develop pharmaceuticals that transform drug resistance into therapeutic advantage. The company was founded by H. Michael Shepard and Geoffrey Myles Wahl in 1997 and is headquartered in San Diego, CA.

New Phoenix Opportunities Corp. engages in the exploration and development of mineral properties. The company was founded on March 21, 2011 and is headquartered in Vancouver, Canada.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team.

Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

Law Society of British Columbia provides legal services. The firm protects the public interest in the administration of justice by setting and enforcing standards of professional conduct for lawyers. The company is headquartered in Vancouver, Canada.

Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY.

Science Magazine is a peer-reviewed academic journal published by the American Association for the Advancement of Science. It is one of the top academic journals in the world and has been in circulation since 1880. The magazine delivers impactful research, daily news, expert commentary, and career resources to its subscriber base of around 130,000. Science is a leading multidisciplinary, international journal that covers breakthroughs and policy analysis and news.

Part of Warner Bros. The company is based in Bethesda, MD. Discovery, Inc., Discovery Channel is a provider of television broadcasting services.

Gale Capital Corp. provides corporate finance and investor relations services to publicly traded companies. It assists the companies in fostering productive, continuing dialogues with analysts, brokers, investors and other financial professionals. The company was founded in 1993 and is headquartered in West Vancouver, Canada.

Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.

ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.

Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium.

Enosi Life Sciences Corp. is a drug research and development company that focuses on providing therapeutics for autoimmune diseases and cancer. The private company is based in San Diego, CA, and was founded in 2018 by H. Michael Shepard and Marc Feldmann. Enosi Life Sciences combines their expertise with Dr. James N. Woody's medical, scientific, and management expertise to expand therapeutic options. The company was founded by Professor Sir Marc Feldmann and Dr. H. Michael Shepard, who are world-renowned scientists in the field of cancer and autoimmune diseases. Patrick W. Gray has been the CEO of the company since 2021.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.